{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:32:59Z","timestamp":1773293579751,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIDA","award":["U01DA034743"],"award-info":[{"award-number":["U01DA034743"]}]},{"DOI":"10.13039\/100006732","name":"New York University","doi-asserted-by":"publisher","award":["U01DA033336"],"award-info":[{"award-number":["U01DA033336"]}],"id":[{"id":"10.13039\/100006732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Friends Research Inc.","award":["U01DA013636"],"award-info":[{"award-number":["U01DA013636"]}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.cct.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T20:01:08Z","timestamp":1465243268000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Injectable pharmacotherapy for opioid use disorders (IPOD)"],"prefix":"10.1016","volume":"49","clinical-trial-number":[{"clinical-trial-number":"nct02110264","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"David","family":"Farabee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Hillhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Condon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"McCrady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"McCollister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2016.06.003_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2105\/AJPH.92.11.1789","article-title":"The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997","volume":"92","author":"Hammett","year":"2002","journal-title":"Am. J. Public Health"},{"issue":"11","key":"10.1016\/j.cct.2016.06.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007558","article-title":"HIV\/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity","volume":"4","author":"Spaulding","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cct.2016.06.003_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2014a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cct.2016.06.003_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cct.2016.06.003_bb0025","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cct.2016.06.003_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jsat.2006.06.006","article-title":"Naltrexone as negative reinforcement: Comments on \u201ca behavioral analysis of coercion in substance abuse treatment.\u201d","volume":"31","author":"Farabee","year":"2006","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2016.06.003_bb0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0740-5472(97)00020-2","article-title":"Naltrexone pharmacotherapy for opioid dependent federal probationers","volume":"14","author":"Cornish","year":"1997","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.cct.2016.06.003_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/17449200701520149","article-title":"Evaluation of a prison-based naltrexone program","volume":"3","author":"Shearer","year":"2007","journal-title":"Int. J. Prison. Health"},{"issue":"Suppl., 12","key":"10.1016\/j.cct.2016.06.003_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.15288\/jsas.1994.s12.70","article-title":"Ensuring balanced distribution of prognostic factors in treatment outcome research","author":"Stout","year":"1994","journal-title":"Journal of Studies on Alcohol"},{"issue":"3","key":"10.1016\/j.cct.2016.06.003_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspectives in Clinical Research"},{"issue":"9776","key":"10.1016\/j.cct.2016.06.003_bb0055","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cct.2016.06.003_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/NCC.0b013e3181c40401","article-title":"Patient navigation in breast cancer: a systematic review","volume":"33","author":"Robinson-White","year":"2010","journal-title":"Cancer Nurs."},{"issue":"S2","key":"10.1016\/j.cct.2016.06.003_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/cncr.22354","article-title":"Improving follow-up to abnormal breast cancer screening in an urban population","volume":"109","author":"Battaglia","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cct.2016.06.003_bb0070","series-title":"Interventions for Helping Patients Follow Prescriptions for Medications","volume":"1","author":"Haynes","year":"2002"},{"key":"10.1016\/j.cct.2016.06.003_bb0075","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.288.22.2868","article-title":"Interventions to enhance patient adherence to medication prescriptions: scientific review","volume":"288","author":"McDonald","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2016.06.003_bb0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2015.10.023","article-title":"Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system","volume":"157","author":"Springer","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.cct.2016.06.003_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst. Abus."},{"key":"10.1016\/j.cct.2016.06.003_bb0090","series-title":"The Risk Assessment Battery (RAB): Validity and Reliability. Presented at Sixth Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS. Alexandria, VA.","author":"Metzger","year":"1993"},{"issue":"5","key":"10.1016\/j.cct.2016.06.003_bb0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a short opiate withdrawal scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addict. Behav."},{"key":"10.1016\/j.cct.2016.06.003_bb0100","series-title":"Measuring Alcohol Consumption","first-page":"41","article-title":"Timeline follow-back","author":"Sobell","year":"1992"},{"issue":"3","key":"10.1016\/j.cct.2016.06.003_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","article-title":"The use of analogue scales in rating subjective feelings","volume":"47","author":"Bond","year":"1974","journal-title":"Br. J. Med. Psychol."},{"issue":"2","key":"10.1016\/j.cct.2016.06.003_bb0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoactive Drugs"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:47:06Z","timestamp":1589669226000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714416300829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":22,"alternative-id":["S1551714416300829"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2016.06.003","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable pharmacotherapy for opioid use disorders (IPOD)","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.cct.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}